General Mills (GIS) Q2 2026 earnings review

Buying Growth: Volume Returns, But Profits Pay the Price

General Mills' strategy to 'restore volume' is technically working, but the bill has arrived. For the first time in recent history, North America Retail delivered positive organic volume growth (+1%), proving consumers respond to price cuts. However, the cost was steep: Adjusted EPS plunged 21% (constant currency) as lower pricing, higher input costs, and increased marketing crushed margins. While management reaffirmed FY26 guidance, the divergence between stabilizing top-line trends and deteriorating profitability raises questions about the long-term sustainability of this 'investment year.'

🐂 Bull Case

Strategy Validation

The 'Remarkability' investment strategy is yielding results where it matters most: North America Retail organic volume turned positive (+1%) after quarters of decline. The company held or gained share in 8 of its top 10 U.S. categories.

International Strength

While the U.S. market requires heavy investment, the International segment is performing robustly, delivering 4% organic sales growth and expanding operating profit by 30% (constant currency).

🐻 Bear Case

Margin Compression

The pivot to value is expensive. Adjusted Gross Margin contracted 150 basis points to 34.8%, and Adjusted Operating Margin fell 290 basis points to 17.4%. The company is essentially subsidizing volume with profitability.

Pet Segment Profitability

Despite a sales boost (+11%) from the Whitebridge acquisition, North America Pet operating profit fell 12%. Higher input costs and SG&A expenses are completely eroding the benefits of top-line expansion.

⚖️ Verdict: 🔴

Bearish. While the return of volume growth is a necessary first step, the efficiency of the P&L has deteriorated significantly. With Adjusted EPS down 21% and margins compressing across key segments, the company is in a difficult transition period that offers little near-term upside for investors.

Key Themes

CONCERNNEW🔴

North America Retail: Pricing Power Evaporates

The core North America Retail segment shows a stark reversal in pricing power. To achieve a 1% gain in organic volume, the company absorbed a 4% hit to Price/Mix. Consequently, segment operating profit collapsed 21%. This suggests demand is highly elastic only to the downside—consumers are buying, but only at significantly lower effective price points.

CONCERN🔴🔴

Pet Segment: Empty Calories Growth

The North America Pet segment reported 11% revenue growth, optically strong due to the Whitebridge acquisition (10-point benefit). However, organic sales were up only 1%, and operating profit actually *declined* 12%. The acquisition and organic growth are currently margin-dilutive, driven by higher input costs and launch support expenses for 'Love Made Fresh.'

DRIVER🟢

International Momentum

International remains the most balanced segment, delivering 4% organic sales growth alongside significant profitability improvements. Segment operating profit surged 30% in constant currency, driven by favorable price/mix and volume growth in key markets like Brazil, China, and India. This segment is effectively executing the strategy that is struggling in North America.

THEMENEW

Portfolio Reshaping Noise

Financial comparability is heavily distorted by M&A activity. The North American Yogurt divestiture created a 10-point headwind to Retail sales, while the Whitebridge acquisition added 10 points to Pet sales. Investors must look past the headline -7% revenue number to see the underlying -1% to -2% organic reality.

DRIVER

Innovation Traction

Investments in 'brand remarkability' and innovation are showing early signs of life. Management noted new product sales are expected to increase 25% in FY26. The stabilization in market share (gaining/holding in 8 of top 10 categories) validates that the new product news is resonating, even if it requires margin investment to move off the shelf.

Other KPIs

Adjusted Gross Margin (26Q2)34.8%

Decelerating. Down 150 basis points YoY. The decline is driven by higher input costs and the inability to offset them with pricing, as price/mix turned negative to spur volume.

Free Cash Flow (6 Months)$1.2 Billion

Decelerating. Operating cash flow dropped from $1.8B in the prior year period to $1.2B, driven by lower net earnings (excluding divestiture gains). This reduces the capital available for buybacks, which slowed to $500M (vs $600M prior year).

Adjusted Diluted EPS (26Q2)$1.10

Reversing. Down 21% in constant currency. This is a sharp deterioration compared to the +12% growth seen in 25Q2, highlighting the rapid shift in the P&L profile this fiscal year.

Guidance

FY26 Organic Net Sales-1% to +1%

Stable. Management reaffirmed this range. Given YTD organic sales are -2%, this implies an acceleration to flat or positive growth in the second half of the fiscal year.

FY26 Adjusted Operating Profit (Constant Currency)-10% to -15%

Stable. Reaffirmed. The sharp Q2 decline (-20%) fits within this grim full-year outlook, suggesting the margin pressure is expected to persist, though potentially moderating slightly in H2.

FY26 Adjusted Diluted EPS (Constant Currency)-10% to -15%

Stable. Reaffirmed. Continues to reflect the 'investment year' thesis where earnings are sacrificed for market share stability.

Key Questions

Profitability of Volume Gains

North America Retail organic volume is finally positive (+1%), but it cost 4 points of price/mix and a 21% drop in segment operating profit. Is this the new baseline margin profile required to hold volume in this environment?

Pet Segment Margins

Pet operating profit declined 12% despite an 11% sales boost from acquisitions. When does the integration of Whitebridge and the 'Love Made Fresh' launch transition from a margin headwind to accretive?

Yogurt Divestiture Stranded Costs

With the Yogurt divestiture now closed, how much of the reported margin compression is due to temporary stranded costs versus structural input cost inflation?

Second Half Acceleration

Guidance implies an improvement in organic sales trends in H2 (-2% YTD vs -1% to +1% FY target). What specific drivers (innovation launch timing, easier comps) underpin this confidence?